Dr Neil Mehta discusses the recent updates on policies for liver transplantation in patients with hepatocellular carcinoma (HCC).
Dr Neil Mehta discusses the recent updates on policies for liver transplantation in patients with hepatocellular carcinoma (HCC).
Dr Neil Mehta underwent medical training at the University of California, San Francisco (UCSF). He was an Intern then a Resident at the Hospital of the University of Pennsylvania before becoming a Fellow in Gastroenterology and Transplant Hepatology at UCSF. He is Associate Professor in Medicine at UCSF and has held this position since 2013. He is specifically interested in issues related to the diagnosis and management of patients with hepatocellular carcinoma (HCC) particularly with regards to outcomes in liver transplantation.
Fujifilm Wako
A 3-part video series on managing early RRMM from leading medical experts
Recommendations for best practice
Paper published in Journal of Gastrointestinal Cancer
Get your free professional profile photos taken with us at Booth 507
Maximising outcomes for patients with advanced neuroendocrine tumours
Clinical application of liquid biopsy, and how it applies to NSCLC, breast and colorectal cancer